Bottomline: PE-backed Integrace’s margins shrink, revenue growth marginally better
Advertisement

Bottomline: PE-backed Integrace’s margins shrink, revenue growth marginally better

By Sreeja Biswas

  • 20 Nov 2024
Premium
Bottomline: PE-backed Integrace’s margins shrink, revenue growth marginally better
Kedar Rajadnye, CEO, Integrace

Drugmaker Integrace Pvt Ltd, which has Indian private equity firm True North and Singapore state investment firm Temasek on its cap table, improved its revenue growth marginally in the financial year ended March 2024, but its margins continued to shrink.  Based in Mumbai, Integrace specializes in musculoskeletal disorders, pain management, and women’s health products ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News